Clal Insurance’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,567,178
Closed -$40.2M 195
2021
Q4
$40.2M Sell
2,567,178
-1,680,400
-40% -$33.9M 0.44% 67
2021
Q3
$87.3M Sell
4,247,578
-55,832
-1% -$1.43M 1% 30
2021
Q2
$105M Buy
4,303,410
+197,533
+5% +$4.89M 1.21% 26
2021
Q1
$114M Buy
+4,105,877
New +$122M 1.32% 26

Other funds holding CGNT

Clal Insurance's CGNT Position: Q1 2022 in Review

Clal Insurance sold out of Cognyte Software (CGNT) in Q1 2022, closing a stake of 2,567,178 shares — an estimated $40.2M sold.

Clal Insurance first reported a position in CGNT in Q1 2021 and held it in 4 quarters. The position peaked at $114M in Q1 2021. 158 funds tracked by Wall St. Rank hold CGNT as of Q1 2022.

  • Clal Insurance reported no remaining Cognyte Software position as of Q1 2022 after selling out during the quarter.
  • Clal Insurance sold 2,567,178 Cognyte Software shares in Q1 2022, an estimated $40.2M.
  • Clal Insurance first reported a position in Cognyte Software in Q1 2021 and held it in 4 quarters.
  • Clal Insurance's Cognyte Software position peaked at $114M in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Cognyte Software as of Q1 2022.

Based on Clal Insurance's 13F filing for Q1 2022, filed 12 May 2022.